Medidata Solutions (www.mdsol.com) helps the world's leading pharmaceutical, biotechnology and medical device companies realize the maximum potential value from their clinical research investments. Working with companies large and small, Medidata Solutions helps accelerate the process of bringing life-enhancing treatments to market – on five continents and in more than 70 countries. Innovative process design, technology and services can streamline clinical trials by providing early visibility to clinical data for faster decision-making, optimized resources and lower execution risk. Medidata Solutions' broad client base and deep clinical experience provide value for the world's leading pharmaceutical, biotechnology and medical device companies, expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects.

Advantage for PharmaLink: The collaboration will provide biopharmaceutical companies earlier visibility into the critical clinical data that leads to better-informed decision making, resource allocation and risk management.